• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment


135.4500 USD 0.7700 0.57%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Illumina Inc (ILMN)

Open: 136.9300 Day's Range: 133.6600 - 138.3300 Volume: 1,123,011
Previous Close: 136.2200 52wk Range: 54.8400 - 183.3000 1-Yr Rtn: +141.49%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 135.4500
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 66.8017
Estimated P/E(12/2014) 65.6250
Relative P/E vs. SPX 3.8845
Earnings Per Share (USD) (ttm) 2.0276
Est. EPS (USD) (12/2014) 2.0640
Est. PEG Ratio 3.4451
Market Cap (M USD) 17,388.26
Shares Outstanding (M) 128.37
30 Day Average Volume 2,350,582
Price/Book (mrq) 11.2836
Price/Sale (ttm) 11.9260
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil